Dynamic Medical Technologies Inc. (TPEX:4138)
Taiwan
· Delayed Price · Currency is TWD 91.60
-0.20 (-0.22%)
Apr 2, 2025, 1:16 PM CST
TPEX:4138 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 1,573 | 1,594 | 1,292 | 1,028 | 1,009 | Upgrade
|
| Revenue | 1,573 | 1,594 | 1,292 | 1,028 | 1,009 | Upgrade
|
| Revenue Growth (YoY) | -1.31% | 23.36% | 25.63% | 1.87% | -14.33% | Upgrade
|
| Cost of Revenue | 943.48 | 990.45 | 839.16 | 673.6 | 691.27 | Upgrade
|
| Gross Profit | 629.22 | 603.05 | 452.53 | 354.58 | 318.04 | Upgrade
|
| Selling, General & Admin | 383.28 | 337.43 | 297.04 | 192.89 | 173.59 | Upgrade
|
| Operating Expenses | 384.13 | 334.5 | 294.2 | 194.16 | 177.19 | Upgrade
|
| Operating Income | 245.09 | 268.56 | 158.33 | 160.42 | 140.85 | Upgrade
|
| Interest Expense | -5.47 | -2.45 | -1.33 | -0.87 | -1.01 | Upgrade
|
| Interest & Investment Income | 33.97 | 27.75 | 14.11 | 6.98 | 11.22 | Upgrade
|
| Earnings From Equity Investments | 1.05 | 1.05 | -2.6 | 0.86 | -2.06 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 1.3 | 7 | -0.59 | -2.69 | Upgrade
|
| Other Non Operating Income (Expenses) | 15.03 | 1.09 | 2.64 | 7.04 | 2.44 | Upgrade
|
| EBT Excluding Unusual Items | 289.67 | 297.31 | 178.16 | 173.82 | 148.75 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.06 | Upgrade
|
| Pretax Income | 289.67 | 297.31 | 178.16 | 173.82 | 148.69 | Upgrade
|
| Income Tax Expense | 51.61 | 59.54 | 38.3 | 32.13 | 32.05 | Upgrade
|
| Earnings From Continuing Operations | 238.06 | 237.76 | 139.86 | 141.69 | 116.64 | Upgrade
|
| Minority Interest in Earnings | -32.66 | -27.44 | -2.75 | -18.48 | -0.65 | Upgrade
|
| Net Income | 205.39 | 210.32 | 137.11 | 123.21 | 116 | Upgrade
|
| Net Income to Common | 205.39 | 210.32 | 137.11 | 123.21 | 116 | Upgrade
|
| Net Income Growth | -2.34% | 53.39% | 11.29% | 6.22% | 3.09% | Upgrade
|
| Shares Outstanding (Basic) | 36 | 36 | 36 | 36 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 36 | 36 | 36 | 36 | 36 | Upgrade
|
| Shares Change (YoY) | -0.06% | -0.05% | -0.07% | -0.02% | 0.04% | Upgrade
|
| EPS (Basic) | 5.66 | 5.79 | 3.78 | 3.39 | 3.20 | Upgrade
|
| EPS (Diluted) | 5.64 | 5.77 | 3.76 | 3.38 | 3.18 | Upgrade
|
| EPS Growth | -2.30% | 53.38% | 11.34% | 6.24% | 3.22% | Upgrade
|
| Free Cash Flow | 126.94 | 290.43 | 162.88 | 235.37 | 240.37 | Upgrade
|
| Free Cash Flow Per Share | 3.49 | 7.97 | 4.47 | 6.45 | 6.59 | Upgrade
|
| Dividend Per Share | - | 6.136 | 2.603 | 3.058 | 2.893 | Upgrade
|
| Dividend Growth | - | 135.72% | -14.87% | 5.71% | 4.48% | Upgrade
|
| Gross Margin | 40.01% | 37.84% | 35.03% | 34.49% | 31.51% | Upgrade
|
| Operating Margin | 15.58% | 16.85% | 12.26% | 15.60% | 13.96% | Upgrade
|
| Profit Margin | 13.06% | 13.20% | 10.62% | 11.98% | 11.49% | Upgrade
|
| Free Cash Flow Margin | 8.07% | 18.23% | 12.61% | 22.89% | 23.82% | Upgrade
|
| EBITDA | 422.86 | 353.33 | 221.05 | 214.53 | 184.25 | Upgrade
|
| EBITDA Margin | 26.89% | 22.17% | 17.11% | 20.87% | 18.25% | Upgrade
|
| D&A For EBITDA | 177.78 | 84.77 | 62.72 | 54.11 | 43.41 | Upgrade
|
| EBIT | 245.09 | 268.56 | 158.33 | 160.42 | 140.85 | Upgrade
|
| EBIT Margin | 15.58% | 16.85% | 12.26% | 15.60% | 13.96% | Upgrade
|
| Effective Tax Rate | 17.82% | 20.03% | 21.50% | 18.49% | 21.55% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.